Cancer, Meet AI

Early Detection, Every Time

Reducing Human Variability in Medicine

Our Vision

We are a team of technologists and physicians who are unified by our common goals

Reduce human variability

Large variability between physicians in a range of clinical disciplines based in visual observation.

Train AI Model to All Cancers

Colon, bladder, lung, blood, bone. Anywhere early detection plays a pivotal role, we will be there.

Reduce the Cost of Care

Increased detection will in most cancers lead to much less aggressive interventions and treatments, leading to happier patients and lower healthcare bill.

How it Works

Machine Learning on Colonoscopies

Our models are trained on thousands of hours of annotated high quality colonoscopy videos. The technology was born out of leading realtime multimedia systems, and has 12 years of research going into it.

Vendor Agnostic Technology

Our AI works like a trained physician - it analyses video in real time. We can connect to any vendor's equipment, be it Olympus, Pentax or FujiFilm to highlight lesions that endoscopists miss.

Real Time Feedback

Augere gives the endoscopist a real time probability of early stage lesions being in the field of view.

Improving Colonoscopy

Individual Endoscopist Performance

On average, more than 20% of polyps are missed in colonoscopies, and the detection rate varies from 3 - 40% in studies.

Making Physicians Even Better

Even physicians have bad days. Losing focus for just a fraction of a second is enough to miss critical polyps. At Augere, we provide a second pair of eyes to catch the easily missed small polyps and flat lesions.

Reducing Variation

Every patient wants the physicians with the most experience. With years of training and 1000s of endoscopies, it takes time for physicians to excel. With Augere's AI we give every patient access to better procedures.

Team

Kjetil Hestdal, MD, PhD

Chairman of the Board

Michael Riegler, PhD

Chief AI Scientist

Tor Jan Berstad

Data Scientist

Partners

Partner With Us

We can't do this alone. We need to work with the leading hospitals, governments, and public health gurus. We are also looking for investors. Drop us a note below and we'd be delighted to pick up the conversation.